Document is current

Article History

Accepted: 17 May 2024

First Online: 15 July 2024

Declarations

:

: JAPF Reports Advisory Board, Speaker, Grant Non-financial Support from Astrazeneca and GSK; Advisory Board and Speaker from MSD and Clovis; Advisory Board, Speaker and Grant from Pharmamar; Advisory Board from Pharmand and Ability pharma. LGG reports Advisory Board—Speaker—Other from GSK, MSD and AstraZeneca; Speaker from Eisai and Advisory Board—Speaker from Clovis Oncology and PharmaMar. AMU reports Advisory Board—Speaker from Astrazeneca and GSK; Speaker from MSD and Clovis and Advisory Board from PharmaMar. FGM reports Advisory Board—Speaker—Non-financial Support from GSK, AstraZeneca, Clovis and PharmaMar; Advisory Board—Speaker from Roche, GSK, AstraZeneca and MSD and Advisory Board—Speaker—Grant from PharmaMar. JAC reports Advisory Board—Speaker—Grant from GSK; Speaker from Roche and Clovis; Advisory Board—Speaker from Astra Zenenca; Speaker—Grant from MSD and Grant from Pharmamar. EGA reports Advisory Board—Speaker from AstraZeneca-MSD, GSK, Pharmamar, Roche and Clovis and Other from GSK. MPBG reports Advisory Board—Speaker—Other from AatraZeneca, GSK, MSD and Roche; Advisory Board from EISAI and Advisory Board—Speaker from AstraZeneca, Clovis, GSK, MSD and Pharmamar. AMF reports Speaker from MSD, Sanofi, Leo Pharma, Health in Code and Roche; Speaker—Grant from AstraZeneca and Advisory Board—Speaker from GSK. CML, MJRP nothing to disclose.

: Compliance with ethical standards. The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: This is a guideline. no patient has been included in any study. No informed consent is required in this case. Limitation in word counting make useless to include any reference to informed consent in papers where "no patient" has been included.